| Angie Mills Harris, DO | |
|
2 Memorial Dr Ste 220, Alton, IL 62002-6723 | |
| (618) 474-1723 | |
| Not Available |
| Full Name | Angie Mills Harris |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 24 Years |
| Location | 2 Memorial Dr Ste 220, Alton, Illinois |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972694685 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 036139138 (Illinois) | Primary |
| 207Q00000X | Family Medicine | 059470 (Georgia) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bjc Home Care Services | Saint louis, MO | Home health agency |
| Alton Memorial Hospital | Alton, IL | Hospital |
| Christian Hospital Northeast | Saint louis, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Fairview Heights Medical Group Sc | 6800784083 | 342 |
| Legacy Healthcare Services Inc | 2163339722 | 2654 |
News Archive
Discovery of a dual role played by the enzyme phosphoglycerate kinase 1 (PGK1) may indicate a new therapeutic target for glioblastoma, an often fatal form of brain cancer, according to researchers at The University of Texas MD Anderson Cancer Center.
A new study in Health Services Research finds nearly three-quarters of physicians using electronic health records (EHRs) in 2011 said there were clinical benefits when patients' medical histories were kept in digital files. The study focused on doctors' perceptions of clinical benefits to patient care when EHRs were in place.
Simcere Pharmaceutical Group (NYSE: SCR) ("Simcere" or the "Company"), a leading manufacturer and supplier of branded generic and innovative pharmaceuticals in China, today announced that Jiangsu Yanshen Biological Technology Stock Co., Ltd ("Jiangsu Yanshen"), in which Simcere holds a 37.5% stake, was awarded a new drug certificate and production license from China's State Food and Drug Administration (SFDA) on September 18 for Jiangsu Yanshen's H1N1 vaccine.
Tengion, Inc., a leader in regenerative medicine, announced today the publication of a key study in the American Journal of Physiology Renal Physiology by researchers at Tengion. In the study, rodents with chronic kidney disease (CKD) were treated with healthy kidney cells to catalyze the regeneration of functional kidney tissue and delay disease progression, as evidenced by extended survival, improved kidney filtration, and reduced severity of kidney tissue pathology.
Protecting ourselves from backyard mosquito bites may come down to leaving the vacuuming for later, a study from York University shows.
› Verified 5 days ago
| Entity Name | Fairview Heights Medical Group Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679503668 PECOS PAC ID: 6800784083 Enrollment ID: O20040309000650 |
News Archive
Discovery of a dual role played by the enzyme phosphoglycerate kinase 1 (PGK1) may indicate a new therapeutic target for glioblastoma, an often fatal form of brain cancer, according to researchers at The University of Texas MD Anderson Cancer Center.
A new study in Health Services Research finds nearly three-quarters of physicians using electronic health records (EHRs) in 2011 said there were clinical benefits when patients' medical histories were kept in digital files. The study focused on doctors' perceptions of clinical benefits to patient care when EHRs were in place.
Simcere Pharmaceutical Group (NYSE: SCR) ("Simcere" or the "Company"), a leading manufacturer and supplier of branded generic and innovative pharmaceuticals in China, today announced that Jiangsu Yanshen Biological Technology Stock Co., Ltd ("Jiangsu Yanshen"), in which Simcere holds a 37.5% stake, was awarded a new drug certificate and production license from China's State Food and Drug Administration (SFDA) on September 18 for Jiangsu Yanshen's H1N1 vaccine.
Tengion, Inc., a leader in regenerative medicine, announced today the publication of a key study in the American Journal of Physiology Renal Physiology by researchers at Tengion. In the study, rodents with chronic kidney disease (CKD) were treated with healthy kidney cells to catalyze the regeneration of functional kidney tissue and delay disease progression, as evidenced by extended survival, improved kidney filtration, and reduced severity of kidney tissue pathology.
Protecting ourselves from backyard mosquito bites may come down to leaving the vacuuming for later, a study from York University shows.
› Verified 5 days ago
| Entity Name | Uptown Emergency Physicians Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811135882 PECOS PAC ID: 8921096850 Enrollment ID: O20040430001269 |
News Archive
Discovery of a dual role played by the enzyme phosphoglycerate kinase 1 (PGK1) may indicate a new therapeutic target for glioblastoma, an often fatal form of brain cancer, according to researchers at The University of Texas MD Anderson Cancer Center.
A new study in Health Services Research finds nearly three-quarters of physicians using electronic health records (EHRs) in 2011 said there were clinical benefits when patients' medical histories were kept in digital files. The study focused on doctors' perceptions of clinical benefits to patient care when EHRs were in place.
Simcere Pharmaceutical Group (NYSE: SCR) ("Simcere" or the "Company"), a leading manufacturer and supplier of branded generic and innovative pharmaceuticals in China, today announced that Jiangsu Yanshen Biological Technology Stock Co., Ltd ("Jiangsu Yanshen"), in which Simcere holds a 37.5% stake, was awarded a new drug certificate and production license from China's State Food and Drug Administration (SFDA) on September 18 for Jiangsu Yanshen's H1N1 vaccine.
Tengion, Inc., a leader in regenerative medicine, announced today the publication of a key study in the American Journal of Physiology Renal Physiology by researchers at Tengion. In the study, rodents with chronic kidney disease (CKD) were treated with healthy kidney cells to catalyze the regeneration of functional kidney tissue and delay disease progression, as evidenced by extended survival, improved kidney filtration, and reduced severity of kidney tissue pathology.
Protecting ourselves from backyard mosquito bites may come down to leaving the vacuuming for later, a study from York University shows.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Angie Mills Harris, DO 2 Memorial Dr Ste 220, Alton, IL 62002-6723 Ph: (618) 474-1723 | Angie Mills Harris, DO 2 Memorial Dr Ste 220, Alton, IL 62002-6723 Ph: (618) 474-1723 |
News Archive
Discovery of a dual role played by the enzyme phosphoglycerate kinase 1 (PGK1) may indicate a new therapeutic target for glioblastoma, an often fatal form of brain cancer, according to researchers at The University of Texas MD Anderson Cancer Center.
A new study in Health Services Research finds nearly three-quarters of physicians using electronic health records (EHRs) in 2011 said there were clinical benefits when patients' medical histories were kept in digital files. The study focused on doctors' perceptions of clinical benefits to patient care when EHRs were in place.
Simcere Pharmaceutical Group (NYSE: SCR) ("Simcere" or the "Company"), a leading manufacturer and supplier of branded generic and innovative pharmaceuticals in China, today announced that Jiangsu Yanshen Biological Technology Stock Co., Ltd ("Jiangsu Yanshen"), in which Simcere holds a 37.5% stake, was awarded a new drug certificate and production license from China's State Food and Drug Administration (SFDA) on September 18 for Jiangsu Yanshen's H1N1 vaccine.
Tengion, Inc., a leader in regenerative medicine, announced today the publication of a key study in the American Journal of Physiology Renal Physiology by researchers at Tengion. In the study, rodents with chronic kidney disease (CKD) were treated with healthy kidney cells to catalyze the regeneration of functional kidney tissue and delay disease progression, as evidenced by extended survival, improved kidney filtration, and reduced severity of kidney tissue pathology.
Protecting ourselves from backyard mosquito bites may come down to leaving the vacuuming for later, a study from York University shows.
› Verified 5 days ago
Dr. Juletta Avagyan, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Memorial Dr, Alton, IL 62002 Phone: 618-463-7240 Fax: 618-463-7216 | |
Dr. Bryan Everett Steele, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4 Memorial Dr Ste 210, Alton, IL 62002 Phone: 618-463-5905 Fax: 618-463-5935 | |
Puja Gurung, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4 Memorial Dr Ste 230, Alton, IL 62002 Phone: 618-433-6616 | |
Mr. William P Robinson Jr., MD Family Medicine Medicare: Medicare Enrolled Practice Location: 815 E 5th Street, Suite 209, Alton, IL 62002 Phone: 618-463-0561 Fax: 618-465-9281 | |
Dr. Anne Ugabi, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1 Memorial Dr, Alton, IL 62002 Phone: 618-463-7311 | |
Dr. Danny Sarwat Shehata, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1 Memorial Dr, Alton, IL 62002 Phone: 618-463-7311 | |
Dr. Sisay Michael Abraham, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2 Memorial Dr Ste 220, Alton, IL 62002 Phone: 618-474-1723 |